Regulation of LPA receptor function by estrogens.

Area of Science:

• Endocrinology
• Cell Biology
• Molecular Pharmacology

Background:

• Lysophosphatidic acid (LPA) receptors are crucial in cellular signaling.
• Estrogen signaling pathways can influence various cellular processes.
• Understanding cross-talk between hormone and lipid signaling is important.

Purpose of the Study:

• To investigate the effect of 17beta-estradiol on LPA1 receptor function.
• To elucidate the molecular mechanisms underlying estrogen-induced LPA1 receptor modulation.
• To identify key signaling molecules involved in this interaction.

Main Methods:

• Stable and transient cell line expression systems (C9 cells).
• Measurement of calcium (Ca2+) mobilization.
• Receptor phosphorylation and internalization assays.
• Confocal microscopy for receptor localization.
• Co-immunoprecipitation for protein-protein interactions.
• Pharmacological inhibition using specific antagonists and kinase inhibitors.

Main Results:

• 17beta-estradiol rapidly induced LPA1 receptor desensitization, evidenced by reduced Ca2+ mobilization.
• Desensitization was associated with LPA1 receptor phosphorylation and internalization.
• These effects were blocked by estrogen receptor antagonist ICI 182780.
• Inhibitors of phosphoinositide 3-kinase (PI3K) and protein kinase C (PKC) also blocked desensitization and phosphorylation.
• PKC alpha was found to associate with LPA1 receptors, with increased association upon 17beta-estradiol treatment.

Conclusions:

• Estrogens modulate LPA1 receptor activity in C9 cells via estrogen receptor alpha.
• The process involves rapid receptor desensitization, phosphorylation, and internalization.
• Protein kinase C alpha and phosphoinositide 3-kinase are key mediators in this estrogen signaling pathway.